United States· US:72482-100_eaca3a36-2256-47c8-ae49-3a866c61a133
Vonjo
A pacritinib product containing pacritinib, registered in United States by Sobi, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PACRITINIB
- Manufacturer
- Sobi, Inc.
- Country
- United States (US)
- ATC code
- L01EJ03
- ATC class
- Pacritinib
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1172482-100-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01EJ03
Pacritinib, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9aa8c2a2-32b5-4c0a-9a9e-abb33f87c324 GET /v1/drugs/9aa8c2a2-32b5-4c0a-9a9e-abb33f87c324?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "PACRITINIB",
"productndc": "72482-100",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA208712",
"marketing_category": "NDA"
}See everything about pacritinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.